Because LMP2A combines with Myc to increase degradation of p27Kip1 in our model, tumor development can occur without the necessity for inactivation of the ARF-Mdm2-p53 pathway, as we have previously observed (24). The gene discussed is CDKN1B; the disease is neoplasm.